Emcure Pharmaceuticals Limited has appointed industry veteran Brijendra Singh as its new Executive Vice President, marking a significant addition to the company’s leadership team.
Singh brings over 40 years of experience in the pharmaceutical sector, with a strong track record in sales leadership, product launches, market strategy, P&L management, and expanding access to essential healthcare solutions in India and globally.
He currently serves as Vertical Head & Vice President – Sales & Marketing for the Cardiology, Diabetes, Metabolic, and Ophthalmology divisions at Lupin Limited, one of the world’s leading multinational pharmaceutical companies. Over the years, he has played a pivotal role in building and mentoring teams, driving the successful development, launch, and market expansion of critical and chronic-care therapies.
Singh’s core expertise spans strategy, pharma marketing, business development, product management, and leadership, making him a valuable asset as Emcure strengthens its portfolio and commercial operations.
